戈利木单抗 - Suppr

Suppr

超能文献

Golimumab.

作者信息

Pappas Dimitrios A, Bathon Joan M, Hanicq Delphine, Yasothan Uma, Kirkpatrick Peter

出版信息

Nat Rev Drug Discov. 2009 Sep;8(9):695-6. doi: 10.1038/nrd2982.

DOI:10.1038/nrd2982

PMID:19721444

Abstract

摘要

相似文献

Golimumab.

Nat Rev Drug Discov. 2009 Sep;8(9):695-6. doi: 10.1038/nrd2982.

Golimumab: in the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

BioDrugs. 2009;23(2):125-35. doi: 10.2165/00063030-200923020-00005.

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?

Reumatismo. 2015 Mar 31;66(4):285-303. doi: 10.4081/reumatismo.2014.799.

Golimumab (simponi) for inflammatory arthritis.

Med Lett Drugs Ther. 2009 Jul 13;51(1316):55-6.

Golimumab: a new anti-TNF-alpha agent for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.

Expert Rev Clin Immunol. 2010 Sep;6(5):721-33. doi: 10.1586/eci.10.49.

Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.

Ann Rheum Dis. 2015 Mar;74(3):538-46. doi: 10.1136/annrheumdis-2013-204195. Epub 2013 Dec 16.

The persistence of golimumab compared to other tumour necrosis factor-α inhibitors in daily clinical practice for the treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: observations from the Slovenian nation-wide longitudinal registry of patients treated with biologic disease-modifying antirheumatic drugs-BioRx.si.

Clin Rheumatol. 2019 Feb;38(2):297-305. doi: 10.1007/s10067-018-4324-7. Epub 2018 Oct 15.

Golimumab: A novel anti-TNF-alpha human monoclonal antibody for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.

Drugs Today (Barc). 2010 Jan;46(1):13-22. doi: 10.1358/dot.2010.46.1.1444434.

The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.

Rheumatology (Oxford). 2013 Oct;52(10):1845-55. doi: 10.1093/rheumatology/ket233. Epub 2013 Jul 9.

Golimumab.

MAbs. 2009 Sep-Oct;1(5):422-31. doi: 10.4161/mabs.1.5.9286. Epub 2009 Sep 15.

引用本文的文献

Abatacept, Golimumab, and Sarilumab as Selected Bio-Originator Disease-Modifying Antirheumatic Drugs with Diverse Mechanisms of Action in Their Current Use in Treatment.

J Clin Med. 2025 Mar 19;14(6):2107. doi: 10.3390/jcm14062107.

Carbon monoxide potentiates the effect of corticosteroids in suppressing inflammatory responses in cell culture.

Bioorg Med Chem. 2025 Apr 1;120:118092. doi: 10.1016/j.bmc.2025.118092. Epub 2025 Jan 31.

High dose trivalent influenza vaccine compared to standard dose vaccine in patients with rheumatoid arthritis receiving TNF-alpha inhibitor therapy and healthy controls: Results of the DMID 10-0076 randomized clinical trial.

Vaccine. 2020 May 13;38(23):3934-3941. doi: 10.1016/j.vaccine.2020.04.002. Epub 2020 Apr 12.

In Search of a Cure for Sepsis: Taming the Monster in Critical Care Medicine.

J Innate Immun. 2016;8(2):156-70. doi: 10.1159/000442469. Epub 2016 Jan 16.

Apoptosis and the FLIP and NF-kappa B proteins as pharmacodynamic criteria for biosimilar TNF-alpha antagonists.

Biologics. 2014 Jul 31;8:211-20. doi: 10.2147/BTT.S57253. eCollection 2014.

Biological products for the treatment of psoriasis: therapeutic targets, pharmacodynamics and disease-drug-drug interaction implications.

AAPS J. 2014 Sep;16(5):938-47. doi: 10.1208/s12248-014-9637-0. Epub 2014 Jul 4.

A multicenter, randomized, double-blind clinical trial of combination therapy with Anbainuo, a novel recombinant human TNFRII:Fc fusion protein, plus methotrexate versus methotrexate alone or Anbainuo alone in Chinese patients with moderate to severe rheumatoid arthritis.

Clin Rheumatol. 2013 Jan;32(1):99-108. doi: 10.1007/s10067-012-2096-z. Epub 2012 Oct 4.

Monoclonal antibodies - a proven and rapidly expanding therapeutic modality for human diseases.

Protein Cell. 2010 Apr;1(4):319-330. doi: 10.1007/s13238-010-0052-8. Epub 2010 May 8.

Fresh from the biologic pipeline-2009.

Nat Biotechnol. 2010 Apr;28(4):307-10. doi: 10.1038/nbt0410-307.

Golimumab and malignancies: true or false association?

Med Oncol. 2011 Jun;28(2):641-8. doi: 10.1007/s12032-010-9490-7. Epub 2010 Apr 7.

本文引用的文献

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.

Lancet. 2009 Jul 18;374(9685):210-21. doi: 10.1016/S0140-6736(09)60506-7. Epub 2009 Jun 26.

Infectious complications of tumor necrosis factor blockade.

Curr Opin Infect Dis. 2009 Aug;22(4):403-9. doi: 10.1097/QCO.0b013e32832dda55.

E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy.

J Rheumatol. 2009 Jul;36(7):1371-9. doi: 10.3899/jrheum.080755. Epub 2009 Jun 1.

Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study.

Arthritis Rheum. 2009 Apr;60(4):976-86. doi: 10.1002/art.24403.

Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study.

Ann Rheum Dis. 2009 Jun;68(6):789-96. doi: 10.1136/ard.2008.099010. Epub 2008 Dec 9.

Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

Arthritis Rheum. 2008 Nov;58(11):3319-29. doi: 10.1002/art.23964.

Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial.

Arthritis Rheum. 2008 Nov;58(11):3402-12. doi: 10.1002/art.23969.

Fully human antibodies from transgenic mouse and phage display platforms.

Curr Opin Immunol. 2008 Aug;20(4):450-9. doi: 10.1016/j.coi.2008.06.004. Epub 2008 Jul 21.

Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study.

Arthritis Rheum. 2008 Apr;58(4):964-75. doi: 10.1002/art.23383.

Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.

Curr Opin Pharmacol. 2007 Aug;7(4):412-7. doi: 10.1016/j.coph.2007.06.001. Epub 2007 Jul 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验